Search Tag: ASPREE

Cardiology Management

Aspree-aspirin-doesn-t-prolong-disability-free-survival-in-healthy-seniors

2018 19 Sep

Results of the Aspirin in Reducing Events in the Elderly (ASPREE) trial indicate that aspirin use in healthy elderly persons (70 years or older) did not prolong disability-free survival over a period of five years but led to a higher rate of major haemorrhage than placebo. The findings are published online in The New England Journal of Medicine. ...Read more